Life Sciences News: Biotech, Pharma, Medtech | LSGN

Digital Health & Health Tech • People & Leadership

Agentic AI gap highlighted across life sciences and pharma organisations

January 15, 2026

Agentic AI in life sciences process orchestration and automation

Pharmaceuticals

Jasper Therapeutics reports positive briquilimab data in chronic spontaneous urticaria

January 14, 2026

Briquilimab chronic spontaneous urticaria clinical examination

Biotechnology • Finance & Investment

Beacon Therapeutics Series C financing raises over $75 million

January 14, 2026

tumour-infiltrating lymphocyte therapy in a research lab

AgriTech & Environmental Life Sciences • Policy, Ethics & Regulation

Waterborne disease poses a growing global threat as water contamination risks rise

January 8, 2026

Wastewater flowing from a sewage outfall pipe onto a shoreline

Digital Health & Health Tech • Pharmaceuticals

Breast cancer remains the world’s most-studied disease area in 2025, Phesi analysis shows

January 8, 2026

Laboratory scientist analysing clinical trial data on a digital analytics platform

Biotechnology • Pharmaceuticals • Policy, Ethics & Regulation

Bayer receives Breakthrough Therapy Designation for sevabertinib in HER2-mutant lung cancer

January 7, 2026

Breakthrough Therapy Designation for sevabertinib supported by oncology research

Biotechnology • Finance & Investment • Pharmaceuticals

Alnylam to invest $250 million in enzymatic ligation platform to expand RNAi manufacturing

January 7, 2026

Alnylam enzymatic ligation platform pharmaceutical manufacturing process

Biotechnology • Pharmaceuticals

Lilly Phase 3 trial shows oral GLP-1 maintains weight loss after injectable therapy

January 7, 2026

Oral GLP-1 therapy tablet manufacturing on pharmaceutical production line

Pharmaceuticals

Sanofi to acquire Dynavax, expanding adult vaccine portfolio

January 7, 2026

Sanofi acquisition of Dynavax vaccine manufacturing vials on automated production line

NEWS

Finance & Investment

Hatteras Venture Partners Raises Over $200 Million in Capital...

August 22, 2025

Hatteras Venture Partners announced the final closings of Hatteras Venture Partners VII (HVP VII)...

Pharmaceuticals

Kite to Acquire Interius BioTherapeutics to Advance In Vivo...

August 22, 2025

Kite, a Gilead Company (Nasdaq: GILD), today announced that it has entered into a definitive...